These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Trimethoprim--a new chemotherapeutic agent]. Midvedt T Tidsskr Nor Laegeforen; 1968 Nov; 88(21):2050. PubMed ID: 5724701 [No Abstract] [Full Text] [Related]
5. [Experimental data on the antibacterial effect of the combination sulfadoxine-trimethoprim]. Böhni E Berl Munch Tierarztl Wochenschr; 1971 Mar; 84(5):87-91. PubMed ID: 4994550 [No Abstract] [Full Text] [Related]
6. [Trimethoprim. Folic acid antagonist--synergistic effect with sulphonamides]. Lykkegaard Nielsen M; Laursen H Nord Med; 1970 Aug; 84(34):1070-3. PubMed ID: 4917032 [No Abstract] [Full Text] [Related]
7. Practical aspects of testing sensitivity to trimethoprim and sulphonamide. Waterworth PM Postgrad Med J; 1969 Nov; 45():Suppl:21-9. PubMed ID: 4902846 [No Abstract] [Full Text] [Related]
8. [Antibacterial effect of sulfanilamide combination drugs]. Metz H; Preac-Mursic V Med Klin; 1972 Dec; 67(49):1626-31. PubMed ID: 4566636 [No Abstract] [Full Text] [Related]
9. Inhibition by pyrimidine analogues of the synthesis of folic acid by trachoma agents. Reeve P; Taverne J; Bushby SR J Gen Microbiol; 1968 Mar; 50(3):Suppl:8. PubMed ID: 5652081 [No Abstract] [Full Text] [Related]
10. Combined antibacterial action in vitro of trimethoprim and sulphonamides. The in vitro nature of synergy. Bushby SR Postgrad Med J; 1969 Nov; 45():Suppl:10-8. PubMed ID: 5361305 [No Abstract] [Full Text] [Related]
11. [An unusual observation in agar diffusion tests with sulfonamides and sulfonamide combination sulfamethoxazol-trimethoprim]. Hussels H; Hussels M Med Lab (Stuttg); 1971 Aug; 24(8):174-9. PubMed ID: 5569688 [No Abstract] [Full Text] [Related]
12. [Growth inhibition zones between polymyxin and sulphonamides]. Breitfellner G Zentralbl Bakteriol Orig A; 1972 Aug; 221(3):357-66. PubMed ID: 4146475 [No Abstract] [Full Text] [Related]
14. Kinetics and mechanisms of action of trimethoprim and sulfonamides, alone or in combination, upon Escherichia coli. Seydel JK; Wempe E; Miller GH; Miller L Chemotherapy; 1972; 17(4):217-58. PubMed ID: 4557279 [No Abstract] [Full Text] [Related]
15. [Further ideas on associations of antimicrobial drugs]. Checcacci L Minerva Med; 1971 Feb; 62(12):521-32. PubMed ID: 5548391 [No Abstract] [Full Text] [Related]
16. Combined action of sulfamethoxazole, trimethoprim, and ethylenediaminetetraacetic acid on Pseudomonas aeruginosa. Rawal BD; Owen WR Appl Microbiol; 1971 Feb; 21(2):367-8. PubMed ID: 4994355 [TBL] [Abstract][Full Text] [Related]
17. The in vivo effect of folinic acid (citrovorum factor) on the potentiation of the antibacterial activity of sulfisoxazole by trimethoprim. Grunberg E; Prince HN; De Lorenzo WF J Clin Pharmacol J New Drugs; 1970; 10(4):231-4. PubMed ID: 4913356 [No Abstract] [Full Text] [Related]
18. Absence of enhancing effect of trimethoprim on the activity of a sulfonamide against Mycobacterium leprae. Pattyn SR; Verdoolaege-Van Loo G Int J Lepr Other Mycobact Dis; 1972; 40(3):320. PubMed ID: 4574275 [No Abstract] [Full Text] [Related]
20. [In vitro testing of Ro 6-2580-9 or Ro 6-2580-11 with the disc test]. Holl KM Chemotherapy; 1969; 14():Suppl:30-7. PubMed ID: 5379871 [No Abstract] [Full Text] [Related] [Next] [New Search]